Effect of foot massage with lavender essential oil in comparison to paraffin oil on restless legs syndrome (RLS) and anxiety levels

Effect of foot massage with lavender essential oil 1.5% in comparison to paraffin oil on the severity of restless legs syndrome and anxiety levels in hemodialysis patients

Status

Recruiting

Phases

Unknown

Study type

Interventional

Source

IRCT

Registry ID

IRCT20210523051370N7

Enrollment

Registered

2022-07-05

Start date

2022-07-02

Completion date

Unknown

Last updated

2022-08-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Restless legs syndrome

Interventions

Intervention 1: The experimental group will receive foot massage with lavender oil. A ten-minute massage (five minutes per foot) from below the knee to the soles of both feet will be performed six tim

Eligibility

Sex/Gender

All

Age

18 Years to 65 Years

Inclusion criteria

Inclusion criteria: Aged 18-65 years Willingness to participate in the study Being conscious (oriented to place, person and time) Continuous treatment with hemodialysis (HD), three times a week for the last 6 months Ability to walk on affected legs independently Having symptoms of restless legs syndrome at least twice a week

Exclusion criteria

Exclusion criteria: Allergic to herbal plants (including essential oils and herbal extracts) Any nervous system, vascular, skeletal and muscular disorders/abnormalities in the lower limbs Simultaneous participation in other research studies investigating the relief of restless legs syndrome History of drug and alcohol abuse Any mental illness, dementia, and intellectual impairment History of deep vein thrombosis Pregnancy and breastfeeding Use of psychiatric and neurological medications Use of other herbal products to relieve Restless Legs Syndrome Withdrawal criteria: Patient's death; Transfer to other hemodialysis centers; Emergency hemodialysis; Any side effects related to the intervention; Missing two hemodialysis sessions; Any interaction between the intervention and patients' medical and nursing care; Unwillingness to continue participation; Eligibility criteria violation.

Design outcomes

Primary

Measure	Time frame
Severity of Restless Legs Syndrome. Timepoint: Baseline (before intervention: T0); Follow-ups (after 6th session: T1; a week after the 6th session: T2). Method of measurement: International Restless Legs Severity Scale.	—

Secondary

Measure	Time frame
Anxiety levels. Timepoint: Baseline (before intervention: T0); Follow-ups (after 6th session: T1; a week after the 6th session: T2). Method of measurement: HADS-anxiety.	—

Countries

Iran (Islamic Republic of)

Contacts

Public ContactDr Seyed Afshin Shorofi

Mazandaran University of Medical Sciences

ashorofi@yahoo.com+98 911 676 6280

Outcome results

None listed

Source: IRCT (via WHO ICTRP) · Data processed: Feb 4, 2026